Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 17 of 25

COMPLETED Phase 2

The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery

NCT01728636

COMPLETED NA

The Effect of Intraoperative Esmolol to Improve Postoperative Quality of Recovery and Pain After Ambulatory Surgery

NCT01782898

COMPLETED Phase 2

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

NCT02025179

COMPLETED

Using Smartphones in the Neonatal Intensive Care Unit

NCT01987180

COMPLETED NA

Improving Rates of Colorectal Cancer Screening Among Never Screened Patients

NCT01742169

COMPLETED NA

Use of Simulation-Based Mastery Learning for Thoracentesis to Improve Outcomes

NCT01898247

COMPLETED NA

Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety

NCT01701284

COMPLETED

Consumer Understanding and Use of Medication Guides

NCT01731405

COMPLETED NA

Maternal-Offspring Metabolics:Family Intervention Trial

NCT01631747

COMPLETED Phase 4

Propofol Versus Sevoflurane Recovery After Gynecological Surgery

NCT01755234

TERMINATED NA

The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study

NCT01743547

TERMINATED NA

Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery

NCT01890707

COMPLETED NA

Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter

NCT02299024

COMPLETED Phase 4

Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

NCT01706146

COMPLETED

Investigation of Efficacy of Improved Acetaminophen Labeling

NCT01592448

COMPLETED NA

Electronic Patient Reported Symptom Assessment

NCT01833637

COMPLETED

Discharge Functional Status and Rehospitalization in the Elderly

NCT02041585

TERMINATED NA

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

NCT01744821

COMPLETED NA

Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle

NCT01769248

COMPLETED Phase 3

A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community

NCT01695278

COMPLETED NA

The Effect of Facial Exercise on the Appearance of Aging

NCT01689012

COMPLETED Phase 2

Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI

NCT01655043

COMPLETED Phase 4

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

NCT01659866

COMPLETED

Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR

NCT01755221

COMPLETED NA

Translating a Heart Disease Lifestyle Intervention Into the Community

NCT01647438

TERMINATED Phase 4

Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

NCT01676415

COMPLETED

Identifying Skin Biopsy Sites

NCT01632644

COMPLETED NA

Mind-Body Health in Uro-Oncology: Research Study

NCT03852030

COMPLETED

Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics

NCT01660139

TERMINATED NA

Effect of Remifentanil on Hemodynamic Stability During Placement of a Mayfield Head Fixation Device for Craniotomy

NCT02430389

COMPLETED Phase 1

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

NCT01473940

COMPLETED Phase 4

Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block

NCT01616173

COMPLETED NA

Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound

NCT02310776

COMPLETED NA

Reducing Disparities in Primary Prevention of Cardiovascular Disease

NCT01610609

COMPLETED NA

JointADventure: A Worksite Activity-Diet Intervention for Chronic Knee Pain

NCT01977872

COMPLETED NA

Lidocaine and Prevention of Chronic Pain

NCT01619852

COMPLETED

Microbiomes of Pelvic Pain

NCT01738464

TERMINATED Phase 4

A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block

NCT01615939

TERMINATED

Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients

NCT01615926

COMPLETED NA

Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer

NCT03149185

COMPLETED NA

Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne

NCT01629797

COMPLETED NA

Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus

NCT01629784

COMPLETED

Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels

NCT01614860

COMPLETED

Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India

NCT01629771

COMPLETED NA

Hydrogel Endovascular Aneurysm Treatment Trial

NCT01407952

COMPLETED NA

Northwestern University and Access Community Health Network Medication Education Study

NCT01578577

COMPLETED NA

Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment

NCT01909973

TERMINATED Phase 4

Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

NCT01929889

TERMINATED NA

Combined Spinal Epidural Urinary Retention

NCT01597791

COMPLETED Phase 4

Duloxetine in Osteoarthritis (OA) Pain

NCT01558700

← Previous Page 17 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.